Briefs

9 Inmates Of Jails In Odisha’s Gajapati Test COVID-19 Positive

By
OB Bureau

Paralakhemundi: As many as 9 inmates in the isolation cell of two jails in Gajapati district have tested positive for COVID-19, said the district administration on Sunday.

Of the nine infected inmates, six in R Udayagiri Sub-Jail and three in Paralakhemundi Sub-Jail have tested positive.

The district administration has begun the contact tracing of the infected inmates while the remaining inmates of these two jails will undergo the COVID-19 test.

OB Bureau

Recent Posts

Delhi & Mumbai Make It To World’s ‘Most Millionaires’ List

New Delhi: Delhi and Mumbai, two of the fastest-growing cities in India, have now made…

May 8, 2024

Know Why Jagannath Temple In Odisha’s Puri Will Remain Closed For 6 Hours Today

Puri: Jagannath Temple in Odisha’s Puri will remain out of bounds for devotees for six…

May 8, 2024

Olympian Neeraj Chopra To Visit Odisha For 27th National Federation Cup Athletics Championships From May 12-15

Bhubaneswar: Neeraj Chopra will be competing in India after a long time. He will be…

May 8, 2024

Trouble For Anubhav Mohanty As Court Dismisses Discharge Plea In Domestic Violence Case

Cuttcak: Actor-turned-politician Anubhav Mohanty again found himself in a soup after the JFMC court here…

May 8, 2024

Mumbai School Sacks Principal For Liking Posts On Palestine

New Delhi: The management of a leading school in Mumbai on Tuesday announced it has…

May 8, 2024

CBI Arrests 4 On Human Trafficking Charges; They Pushed Indians To Russia-Ukraine War Zone

New Delhi: The Central Bureau of Investigation (CBI) on Tuesday said that it has arrested…

May 8, 2024

BJP Intensifies Odisha Campaigning: Rajnath Singh, Chhattisgarh CM To Address Rallies Today

Bhubaneswar: Defence Minister Rajnath Singh will address Vijay Sankalp rallies in Bhawanipatna and Rayagada on…

May 8, 2024

AstraZeneca Withdraws COVID Vaccine Globally; Here’s Why

New Delhi: After admitting that its COVID-19 vaccine can cause rare side effects, AstraZeneca has…

May 8, 2024